Staff perspectives on the impacts of the COVID-19 pandemic on the provision of emergency department care for patients who use opioids.  Gehring ND, Weicker SA, Hyshka E, Lail P, Mrochuk M, Rittenbach K, Speed KA, Salvalaggio G, Harvey G, Twan…

Lessons from COVID-19: Perspectives of senior managers and decision-makers in substance use services in Wales.  Murray S, Holloway K, Buhociu M, Blakebrough M, Phipps C.  Subst Abuse Treat Prev Policy. 2026 Mar 12;21(1):22. doi: 10.1186/…

Clinical outcomes from a mid-western opioid treatment program during covid-19 emergency regulations: a brief report on the effect of tetrahydrocannabinol (THC) use on take home methadone access.  LaCourt ET, Ibekie O, Dike CC, Jegede O. …

Narrative Review of Opioid Use Disorder Treatment Changes During the COVID-19 Pandemic and Their Impact on American Indian/Alaska Native Communities.  Bingham-Hendricks C, Peters-Mosquera A, Aronowitz SV, Woods C, Aronowitz T.  Nurs Open…

Adapting opioid therapy: real-world analysis of switching from methadone to slow-release morphine and back amid COVID-19 supply chain disruptions.  Barkus A, Subata E, Jakavičius H, Barkienė L, Lydekaitė E, Zdanavičius L, Likatavičius G, Širvi…

Rurality weakens the positive association between the COVID-19 pandemic and substance use treatment involving medications for opioid use disorder.  Lofaro RJ, Confer LM, Bohler RM, Schwind JS.  Drug Alcohol Depend Rep. 2026 Jan 5;18:1004…